Cargando…

What causes type 1 diabetes? Lessons from animal models

To study type 1 diabetes (T1D), excellent animal models exist, both spontaneously diabetic and virus-induced. Based on knowledge from these, this review focuses on the environmental factors leading to T1D, concentrated into four areas which are: (1) The thymus-dependent immune system: T1D is a T cel...

Descripción completa

Detalles Bibliográficos
Autor principal:	Buschard, Karsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	What Causes Type 1 Diabetes? Lessons from Animal Models
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132448/ https://www.ncbi.nlm.nih.gov/pubmed/21143521 http://dx.doi.org/10.1111/j.1600-0463.2011.02765.x

Ejemplares similares

Antibiotic treatment during early childhood and risk of type 1 diabetes in children: A national birth cohort study
por: Antvorskov, Julie Christine, et al.
Publicado: (2020)

Type 1 Diabetes at a Crossroads!
por: Cefalu, William T., et al.
Publicado: (2015)

Increased tissue factor activity promotes thrombin generation at type 1 diabetes onset in children
por: Jasser‐Nitsche, Hildegard, et al.
Publicado: (2020)

Extended family history of type 1 diabetes in HLA‐predisposed children with and without islet autoantibodies
por: Kuusela, Salla, et al.
Publicado: (2020)

Insulin resistance relates to DKA severity and affects insulin requirement in children with type 1 diabetes at onset
por: Mastromauro, Concetta, et al.
Publicado: (2022)

Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes
por: Cerqueiro Bybrant, Mara, et al.
Publicado: (2020)

HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
por: Salami, Falastin, et al.
Publicado: (2022)

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results
por: Winkler, Christiane, et al.
Publicado: (2019)

Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes
por: Ilonen, Jorma, et al.
Publicado: (2022)

Human plasma‐derived alpha(1)‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study
por: Lagarde, William H., et al.
Publicado: (2020)

Substitution among milk and yogurt products and the risk of incident type 2 diabetes in the EPIC‐NL cohort
por: Stuber, J. M., et al.
Publicado: (2020)

New animal model of chronic gout reproduces pathological features of the disease in humans
por: Wang, Jiwei, et al.
Publicado: (2023)

Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
por: Strain, William David, et al.
Publicado: (2017)

Stochastic, individual animal systems simulation model of beef cow–calf production: development and validation
por: Aherin, Dustin G, et al.
Publicado: (2022)

Effects of potato resistant starch intake on insulin sensitivity, related metabolic markers and appetite ratings in men and women at risk for type 2 diabetes: a pilot cross‐over randomised controlled trial
por: Sanders, L. M., et al.
Publicado: (2020)

Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 1 diabetes
por: Saleh, Nada M, et al.
Publicado: (2011)

Size matters: Influence of center size on quality of diabetes control in children and adolescents with type 1 diabetes—A longitudinal analysis of the DPV cohort
por: Hackl, Lukas, et al.
Publicado: (2021)

Role of Type 1 Diabetes–Associated SNPs on Autoantibody Positivity in the Type 1 Diabetes Genetics Consortium: Overview
por: Rich, Stephen S., et al.
Publicado: (2015)

Lower HbA1c in patients with type 1 diabetes and celiac disease who reached celiac‐specific antibody‐negativity—A multicenter DPV analysis
por: Nagl, Katrin, et al.
Publicado: (2019)

Mixed‐meal tolerance test to assess residual beta‐cell secretion: Beyond the area‐under‐curve of plasma C‐peptide concentration
por: Ruan, Yue, et al.
Publicado: (2019)

Viral infection‐related gene upregulation in monocytes in children with signs of β‐cell autoimmunity
por: Valta, Milla, et al.
Publicado: (2022)

Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop
por: Wenzlau, Janet M., et al.
Publicado: (2015)

Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes
por: Brorsson, Caroline A., et al.
Publicado: (2015)

Summary of the Type 1 Diabetes Genetics Consortium Autoantibody Workshop
por: Rich, Stephen S., et al.
Publicado: (2015)

Genetics of Autoimmune Thyroiditis in Type 1 Diabetes Reveals a Novel Association With DPB1*0201: Data From the Type 1 Diabetes Genetics Consortium
por: Kahles, Heinrich, et al.
Publicado: (2015)

Contrasting the Genetic Background of Type 1 Diabetes and Celiac Disease Autoimmunity
por: Gutierrez-Achury, Javier, et al.
Publicado: (2015)

An Effective Diabetic Ketoacidosis Prevention Intervention in Children With Type 1 Diabetes
por: Vitale, Rebecca J., et al.
Publicado: (2018)

Design and Measurement of Nonislet-Specific Autoantibodies for the Type 1 Diabetes Genetics Consortium Autoantibody Workshop
por: Akolkar, Beena, et al.
Publicado: (2015)

ATPase4A Autoreactivity and Its Association With Autoimmune Phenotypes in the Type 1 Diabetes Genetics Consortium Study
por: Wenzlau, Janet M., et al.
Publicado: (2015)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

The Vildagliptin Experience — 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration
por: Foley, James E, et al.
Publicado: (2017)

Clinical Safety and Tolerability of Vildagliptin — Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance
por: Mathieu, Chantal, et al.
Publicado: (2017)

Focus On: The Use of Animal Models for the Study of Fetal Alcohol Spectrum Disorders
por: Wilson, Shannon E., et al.
Publicado: (2011)

Management of Type 1 Diabetes in Pregnancy
por: Feldman, Anna Z., et al.
Publicado: (2016)

The Role of Epigenetics in Type 1 Diabetes
por: Jerram, Samuel T., et al.
Publicado: (2017)

The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy
por: Johnson, Nathan M., et al.
Publicado: (2013)

Cardiac protection of germinated brown rice extract in rabbit model of chronic myocardial infarction
por: Petchdee, Soontaree, et al.
Publicado: (2020)

Accelerated model of lupus autoimmunity and vasculopathy driven by toll-like receptor 7/9 imbalance
por: Liu, Yudong, et al.
Publicado: (2018)

A standardized model to study effects of varying 24-h colostrum dose on postnatal growth and development
por: Suárez-Trujillo, Aridany, et al.
Publicado: (2020)

Technical note: novel delivery methods for an enterotoxigenic Escherichia coli infection model in MUC4-locus sequenced weaner pigs()
por: Sterndale, Samantha O, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mfhiupmlrser2uvgdn7hp7qa3v